[1]
|
Wu, P. (2007) Thyroid Disorders and Diabetes. It Is Common for a Person to Be Affected by both Thyroid Disease and Diabetes. Diabetes Self-Management, 24, 80-82, 85-87.
|
[2]
|
Altomare, M., La Vignera, S., Asero, P., Recupero, D., et al. (2013) High Prevalence of Thyroiddysfunction in Pregnant Women. Journal of Endocrinological Investigation, 36, 407-411.
|
[3]
|
Davies, M.J., Aroda, V.R., Collins, B.S., Gabbay, R.A., et al. (2022) Management of Hyperglycaemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Associa-tion for the Study of Diabetes (EASD). Diabetologia, 65, 1925-1966. https://doi.org/10.1007/s00125-022-05787-2
|
[4]
|
Bailey, C.J. (2017) Metformin: Historical Overview. Diabetolo-gia, 60, 1566-1576.
https://doi.org/10.1007/s00125-017-4318-z
|
[5]
|
Triggle, C.R., Mohammed, I., Bshesh, K., Marei, I., et al. (2022) Metformin: Is It a Drug for All Reasons and Diseases? Metabolism, 133, Article ID: 155223. https://doi.org/10.1016/j.metabol.2022.155223
|
[6]
|
Andújar-Plata, P., Pi-Sunyer, X. and Laferrère, B. (2012) Metformin Effects Revisited. Diabetes Research and Clinical Practice, 95, 1-9. https://doi.org/10.1016/j.diabres.2011.09.022
|
[7]
|
Krysiak, R., Szkrobka, W. and Okopien, B. (2015) The Effect of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Patients with Type 2 Diabetes and Subclinical Hyperthyroid-ism. Experimental and Clinical Endocrinology & Diabetes, 123, 205-208. https://doi.org/10.1055/s-0034-1398621
|
[8]
|
Nelson, L.E., Valentine, R.J., Cacicedo, J.M., Gauthier, M.S., et al. (2012) A Novel Inverse Relationship between Metformin-Triggered AMPK-SIRT1 Signaling and p53 Protein Abun-dance in High Glucose-Exposed HepG2 Cells. American Journal of Physiology-Cell Physiology, 303, C4-C13. https://doi.org/10.1152/ajpcell.00296.2011
|
[9]
|
Caton, P.W., Nayuni, N.K., Kieswich, J., Khan, N.Q., et al. (2010) Metformin Suppresses Hepatic Gluconeogenesis through Induction of SIRT1 and GCN5. Journal of Endocrinology, 205, 97-106. https://doi.org/10.1677/JOE-09-0345
|
[10]
|
Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., et al. (2010) Quantification of Metformin by the HPLC Method in Brain Regions, Cerebrospinal Fluid and Plasma of Rats Treated with Lipopolysaccharide. Pharmacological Reports, 62, 956-965. https://doi.org/10.1016/S1734-1140(10)70357-1
|
[11]
|
Al-Alusi, M.A., Du, L., Li, N., Yeh, M.W., et al. (2015) Metformin Does Not Suppress Serum Thyrotropin by Increasing Levothyroxine Absorption. Thyroid, 25, 1080-1084. https://doi.org/10.1089/thy.2015.0211
|
[12]
|
Su, X., Peng, H., Chen, X., Wu, X., et al. (2022) Hyperlipidemia and Hypothyroidism. Clinica Chimica Acta, 527, 61-70.
https://doi.org/10.1016/j.cca.2022.01.006
|
[13]
|
Isidro, M.L., Penín, M.A., Nemiña, R. and Cordido, F. (2007) Met-formin Reduces Thyrotropin Levels in Obese, Diabetic Women with Primary Hypothyroidism on Thyroxine Replacement Therapy. Endocrine, 32, 79-82.
https://doi.org/10.1007/s12020-007-9012-3
|
[14]
|
Morteza Taghavi, S., Rokni, H. and Fatemi, S. (2011) Metformin Decreases Thyrotropin in Overweight Women with Polycystic Ovarian Syndrome and Hypothyroidism. Diabetes and Vascular Disease Research, 8, 47-48.
https://doi.org/10.1177/1479164110391917
|
[15]
|
Walczak, K. and Sieminska, L. (2021) Obesity and Thyroid Axis. International Journal of Environmental Research and Public Health, 18, Article No. 9434. https://doi.org/10.3390/ijerph18189434
|
[16]
|
Guo, F., Bakal, K., Minokoshi, Y. and Hollenberg, A.N. (2004) Lep-tin Signaling Targets the Thyrotropin-Releasing Hormone Gene Promoter in Vivo. Endocrinology, 145, 2221-2227. https://doi.org/10.1210/en.2003-1312
|
[17]
|
Asvold, B.O., Bjøro, T. and Vatten, L.J. (2013) Associations of TSH Levels within the Reference Range with Future Blood Pressure and Lipid Concentrations: 11-Year Follow-Up of the HUNT Study. European Journal of Endocrinology, 169, 73-82. https://doi.org/10.1530/EJE-13-0087
|
[18]
|
Cannarella, R., Condorelli, R.A., Barbagallo, F., Aversa, A., et al. (2021) TSH Lowering Effects of Metformin: A Possible Mechanism of Action. Journal of Endocrinological Investigation, 44, 1547-1550.
https://doi.org/10.1007/s40618-020-01445-9
|
[19]
|
米娜, 杨历新. 二甲双胍在治疗甲状腺结节合并胰岛素抵抗患者中的应用效果及对血清TSH、FT3、FT4影响的研究[J]. 贵州医药, 2018, 42(9): 1052-1054.
|
[20]
|
Lupoli, R., Di Minno, A., Tortora, A., Ambrosino, P., et al. (2014) Effects of Treatment with Metformin on TSH Levels: A Me-ta-Analysis of Literature Studies. The Journal of Clinical Endocrinology & Metabolism, 99, E143-E148.
https://doi.org/10.1210/jc.2013-2965
|
[21]
|
Santos-Palacios, S., Brugos-Larumbe, A., Guillén-Grima, F., Garmen-dia-Madariaga, A., et al. (2015) Does Metformin Have a “Buffer Effect” on Serum TSH Levels in Euthyroid Diabetic Patients? Hormones (Athens), 14, 280-285.
https://doi.org/10.14310/horm.2002.1559
|
[22]
|
Díez, J.J. and Iglesias, P. (2013) Relationship between Serum Thy-rotropin Concentrations and Metformin Therapy in Euthyroid Patients with Type 2 Diabetes. Clinical Endocrinology (Oxford), 78, 505-511.
https://doi.org/10.1111/j.1365-2265.2012.04468.x
|
[23]
|
Wang, J., Gao, J., Fan, Q., Li, H., et al. (2019) The Effect of Metformin on Thyroid-Associated Serum Hormone Levels and Physiological Indexes: A Meta-Analysis. Current Pharmaceutical Design, 25, 3257-3265.
https://doi.org/10.2174/1381612825666190918162649
|
[24]
|
Dimic, D., Golubovic, M.V., Radenkovic, S., Ra-dojkovic, D., et al. (2016) The Effect of Metformin on TSH Levels in Euthyroid and Hypothyroid Newly Diagnosed Diabetes Mellitus Type 2 Patients. Bratislavske Lekarske Listy, 117, 433-435. https://doi.org/10.4149/BLL_2016_084
|
[25]
|
张艳飞, 叶嘉欣. 二甲双胍对2型糖尿病患者甲状腺功能的影响[J]. 中国医学创新, 2020, 17(31): 122-125.
|
[26]
|
杨丽娟, 陈静, 陶红. 二甲双胍对甲状腺功能正常的2型糖尿病患者血清促甲状腺激素水平的影响[J]. 中国综合临床, 2020, 36(6): 481-485.
|
[27]
|
Udovcic, M., Pena, R.H., Patham, B., Tabatabai, L., et al. (2017) Hypothyroidism and the Heart. Methodist DeBakey Cardiovascular Journal, 13, 55-59. https://doi.org/10.14797/mdcj-13-2-55
|
[28]
|
Vigersky, R.A., Filmore-Nassar, A. and Glass, A.R. (2006) Thyrotro-pin Suppression by Metformin. The Journal of Clinical Endocrinology & Metabolism, 91, 225-227. https://doi.org/10.1210/jc.2005-1210
|
[29]
|
张冬磊, 杨宁. 二甲双胍治疗2型糖尿病与亚临床甲状腺功能减退症关系的研究[J]. 中国糖尿病杂志, 2015, 23(3): 248-250.
|
[30]
|
Krysiak, R. and Okopien, B. (2015) The Effect of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Women with Polycystic Ovary Syndrome and Subclinical Hypothyroidism. The Journal of Clinical Pharmacology, 55, 45-49.
https://doi.org/10.1002/jcph.373
|
[31]
|
Haroon, S.M., Khan, K., Maqsood, M., Iqbal, S., et al. (2021) Exploring the Effect of Metformin to Lower Thyroid-Stimulating Hormone in Euthyroid and Hypothyroid Type-2 Diabetic Patients. Cureus, 13, e13283.
https://doi.org/10.7759/cureus.13283
|
[32]
|
Palui, R., Sahoo, J., Kamalanathan, S., Kar, S.S., et al. (2019) Effect of Metformin on Thyroid Function Tests in Patients with Subclinical Hypothyroidism: An Open-Label Randomised Con-trolled Trial. Journal of Endocrinological Investigation, 42, 1451-1458. https://doi.org/10.1007/s40618-019-01059-w
|
[33]
|
杨曙晖. 二甲双胍对2型糖尿病合并亚临床甲状腺功能异常患者的影响[J]. 临床军医杂志, 2011, 39(1): 91-92.
|
[34]
|
Hu, X., Liu, Y., Wang, C., Hou, L., et al. (2017) Metfor-min Affects Thyroid Function in Male Rats. Oncotarget, 8, 107589-107595. https://doi.org/10.18632/oncotarget.22536
|